Allgens Medical Technology CO., LTD. (688613.SS)

CNY 18.52

(0.76%)

Market Cap (In CNY)

2.51 Billion

Revenue (In CNY)

226.47 Million

Net Income (In CNY)

54.23 Million

Avg. Volume

2.43 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.58-22.49
PE
-
EPS
-
Beta Value
0.509
ISIN
CNE1000051W7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Ling Wang
Employee Count
-
Website
https://www.allgensmed.com
Ipo Date
2021-05-21
Details
Allgens Medical Technology CO., LTD., a medical device company, develops and manufactures platforms of biomimetic synthetic bone grafts for use in regions of compromised cancellous and cortical bone worldwide. The company offers BonGold mineralized collagen scaffold bone graft; Alligator high performance bone marrow aspirator; and OssaNova mineralized collagen-based bone filling augmentation material. Its products are used in various skeletal applications in and around the human skeleton. Allgens Medical Technology CO., LTD. was founded in 2004 and is based in Beijing, China.